| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| FOSTER JAMES C | Chairman, President and CEO, Director | C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON | /s/ James C. Foster | 02 Feb 2026 | 0001141722 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRL | Common Stock | Award | $0 | +39,031 | +17% | $0.000000 | 268,341 | 30 Jan 2026 | Direct | F1, F2 |
| transaction | CRL | Common Stock | Tax liability | $3,104,076 | -14,664 | -5.5% | $211.68 | 253,677 | 30 Jan 2026 | Direct | |
| holding | CRL | Common Stock | 5,423 | 30 Jan 2026 | 2024 GRAT | ||||||
| holding | CRL | Common Stock | 20,000 | 30 Jan 2026 | 2025 GRAT | ||||||
| holding | CRL | Common Stock | 230 | 30 Jan 2026 | by Trust | ||||||
| holding | CRL | Common Stock | 750 | 30 Jan 2026 | By Trust | ||||||
| holding | CRL | Common Stock | 2,250 | 30 Jan 2026 | By Trust | ||||||
| holding | CRL | Common Stock | 10,000 | 30 Jan 2026 | Held By Spouse |
| Id | Content |
|---|---|
| F1 | Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 26, 2023. |
| F2 | Reflects the exempt transfer pursuant to Rule 16a-13 of (i) 14,577 shares from the 2024 GRAT account to direct holdings; and (ii) 4,048 shares from the 2022 GRAT account to direct holdings. |